Venous thrombosis in Emergency Department: Diagnosis, treatment, and disposition

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue SUPPL. 1, 2012, Pages 48-56

  Rosa, Antonello ^a   Cipollone, L ^a   Bertazzoni, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Emergency Department; Pulmonary embolism; TDeep venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTITHROMBIN; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5 LEIDEN; D DIMER; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE; UROKINASE;

AGING; ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; B SCAN; BACTERIAL ENDOCARDITIS; BLEEDING; BLEEDING DISORDER; BLOOD CLOT LYSIS; BLOOD PROTEIN DISORDER; BODY MASS; BRAIN TUMOR; CANCER PATIENT; CAST APPLICATION; CATHETER DIRECTED THROMBOLYSIS; CENTRAL VENOUS CATHETERIZATION; CHEMOTHERAPY; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL EXAMINATION; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPRESSION GARMENT; CONCENTRATION (PARAMETERS); CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DIABETIC RETINAL HEMORRHAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; DUODENUM ULCER; DYSFIBRINOGENEMIA; EARLY DIAGNOSIS; EMERGENCY WARD; ENTERITIS; FIBRINOLYSIS; GENE MUTATION; GERIATRIC PATIENT; HEART INFARCTION; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; HYPERTENSION; IMMOBILIZATION; INJURY; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTERNAL MEDICINE; KIDNEY FAILURE; LIFE EXPECTANCY; LIVER FAILURE; LUNG EMBOLISM; MEDICAL DECISION MAKING; MORBIDITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM; NEUROLOGIC DISEASE; OBESITY; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PLASMINOGEN DEFICIENCY; POLYCYTHEMIA VERA; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; PREGNANCY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PUERPERIUM; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEPSIS; SPINAL CORD INJURY; STOMACH ULCER; STROKE; SURGICAL TECHNIQUE; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; VENA CAVA FILTER;

ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POLYSACCHARIDES; RISK FACTORS; STOCKINGS, COMPRESSION; THROMBECTOMY; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; TOMOGRAPHY, SPIRAL COMPUTED; VENA CAVA FILTERS; VENOUS THROMBOSIS; VITAMIN K;

EID: 84860204450     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. SANDLER DA, MARTIN JF. Autopsy proven pulmonary embolism in hospital patients:are we detecting enough deep vein thrombosis? J Ray Soc Med 1989; 82: 203-205. (Pubitemid 19086881)
2. KAHN SR, SHBAKLO H, LAMPING DL, HOLCROFT CA, SHRIER I, MIRON MJ, ROUSSIN A, DESMARAIS S, JOYAL F, KASSIS J, SOLYMOSS S, DESJARDINS L, JOHRI M, GINSBERG JS. Determinants of health related quality of life during the 2 years following deep venous thrombosis. J Thromb Haemost 2008; 6: 1105-1112. (Pubitemid 351859119)
3. TAPSON VF. Acute pulmonary embolism. N Engl J Med 2008; 358: 1037-1052.
4. WELLS P, ANDERSON R, BORMANIS J, GUY F, MITCHELL M, GRAY L, CLEMENT C, ROBINSON KS, LEWANDOWSKI B. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350: 1795-1801.
5. KEARON C, KAHN SR, AGNELLI G, GOLDHABER S, RASKOB GE, COMEROTA AJ. Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest. 2008; 133(6 Suppl): 454S-545S. Erratum in: Chest. 2008; 134: 892.
6. ELIAS A, MALLARD L, ELIAS M, ALQUIER C, GUIDOLIN F, GAUTHIER B, VIARD A, MAHOUIN P, VINEL A, BOCCALON H. A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limbs. Thromb Haemost 2003; 89: 221-227. (Pubitemid 36227271)
7. ZIERLER BK. Ultrasonography and diagnosis of venous thromboembolism, Circulation 2004; 109(12 Suppl 1); I9-19.
8. LE GAL G, RIGHINI M, SANCHEZ O, ROY PM, BABAAHMED M, PERRIER A, BOUNAMEAUX H. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006; 95: 963-966. (Pubitemid 43933753)
9. POLLACK CV Jr. Advanced management of acute iliofemoral deep venous thrombosis: Emergency Department and beyond. Ann Emerg Med 2011; 57: 590-599.
10. STREIFF MB. Diagnosis and initial treatment of venous thromboembolism in patiens with cancer. J Clin Oncol 2009; 27: 4889-4894.
11. STEIN PD, KAYALI F, HULL RD. Spiral computed tomography for the diagnosis of acute pulmonary embolism. Thromb Haemost 2007; 98: 713-720. (Pubitemid 47555060)
12. GOLDHABER SZ, TURPIE AG. Prevention of venous thromboembolism among hospitalized medical patients. Circulation 2005; 111: E1-3.
13. KAHN SR, SHBAKLO H, LAMPING DL, HOLCROFT CA, SHRIER I, MIRON MJ, ROUSSIN A, DESMARAIS S, JOYAL F, KASSIS J, SOLYMOSS S, DESJARDINS L, JOHRI M, GINSBERG JS. Determinants of health related quality of life during the 2 years following deep venous thrombosis. J Thromb Haemost 2008; 6: 1105-1112. (Pubitemid 351859119)
14. GEERTS WH, BERGQVIST D, PINEO GF, HEIT JA, SAMAMA CM, LASSEN MR, COLWELL CW; AMERICAN COLLEGE OF CHEST PHYSICIANS. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S. (Pubitemid 351894916)
15. SAMAMA MM, COHEN AT, DARMON JY, DESJARDINS L, ELDOR A, JANBON C, LEIZOROVICZ A, NGUYEN H, OLSSON CG, TURPIE AG, WEISSLINGER N. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800. (Pubitemid 29420474)
16. TAPSON VF, DECOUSUS H, PINI M, CHONG BH, FROEHLICH JB, MONREAL M, SPYROPOULOS AC, MERLI GJ, ZOTZ RB, BERGMANN JF, PAVANELLO R, TURPIE AG, NAKAMURA M, PIOVELLA F, KAKKAR AK, SPENCER FA, FITZGERALD G, ANDERSON FA JR; IMPROVE INVESTIGATORS. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132: 936-945.
17. LEIZOROVICZ A, COHEN AT, TURPIE AG, OLSSON CG, VAITKUS PT, GOLDHABER SZ; PREVENT MEDICAL THROMBOPROPHYLAXIS STUDY GROUP. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-879. (Pubitemid 39096017)
18. SHERMAN DG, ALBERS GW, BLADIN C, FIESCHI C, GABBAI AA, KASE CS, O'RIORDAN W, PINEO GF; PREVAIL INVESTIGATORS. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): An open-label randomised comparison. Lancet 2007; 369; 1347-1355. (Pubitemid 46621092)
19. TORBICKI A, PERRIER A, KONSTANTINIDES S, AGNELLI G, GALIÈ N, PRUSZCZYK P, BENGEL F, BRADY AJ, FERREIRA D, JANSSENS U, KLEPETKO W, MAYER E, REMY-JARDIN M, BASSAND JP; ESC COMMITTEE FOR PRACTICE GUIDELINES (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
20. AGNELLI G, BECATTINI C. Acute pulmonary embolism. N Engl J Med 2010; 363: 266-274.
21. JAFF MR, MCMURTRY MS, ARCHER SL, CUSHMAN M, GOLDENBERG N, GOLDHABER SZ, JENKINS JS, KLINE JA, MICHAELS AD, THISTLETHWAITE P, VEDANTHAM S, WHITE RJ, ZIERLER BK; AMERICAN HEART ASSOCIATION COUNCIL ON CARDIOPULMONARY, CRITICAL CARE, PERIOPERATIVE AND RESUSCITATION; AMERICAN HEART ASSOCIATION COUNCIL ON PERIPHERAL VASCULAR DISEASE; AMERICAN HEART ASSOCIATION COUNCIL ON ARTERIOSCLEROSIS, THROMBOSIS AND VASCULAR BIOLOGY. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: A scientific statement from the American Heart Association. Circulation 2011; 123: 1788-1830.
22. INGBER S, GEERTS WH. Vena caval filters: Current knowledge, uncertainties and practical approaches. Curr Opin Hematol 2009 ;16: 402-406.
23. HULL RD, SCHELLONG SM, TAPSON VF, MONREAL M, SAMAMA MM, NICOL P, VICAUT E, TURPIE AG, YUSEN RD; EXCLAIM (EXTENDED PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM IN ACUTELY ILL MEDICAL PATIENTS WITH PROLONGED IMMOBILIZATION) STUDY. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: A randomized trial. Ann Intern Med 2010; 153: 8-18.
24. AGNELLI G, VERSO M. Thromboprophylaxis during chemotherapy in patients with advanced cancer. Thromb Res 2010; 125(Suppl 2): S17-20.
25. COMEROTA AJ, PAOLINI D. Treatment of acute iliofemoral deep venous thrombosis: A strategy of thrombus removal. Eur J Vasc Endovasc Surg 2007; 33: 351-360. (Pubitemid 46196401)